Harbin Medical University
Clinical trials sponsored by Harbin Medical University, explained in plain language.
-
New pill combo aims to fight stomach cancer when first treatment fails
Disease control Recruiting nowThis study tests whether taking oral paclitaxel plus fruquintinib can help people with advanced stomach or gastroesophageal junction cancer after their first treatment stops working. About 150 adults will receive either the new drug combo or standard chemotherapy chosen by their …
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
10-Hour eating window may stop weight regain, new study tests
Disease control Recruiting nowThis study tests whether limiting eating to a 10-hour window each day helps overweight or obese adults maintain weight loss after losing at least 5% of their body weight. About 500 participants across China will follow either the time-restricted eating plan or standard weight-mai…
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New study aims to decode heart attack risks by analyzing plaque and immune cells
Knowledge-focused Recruiting nowThis study looks at different types of plaque in the arteries of people with coronary artery disease. Researchers will use special imaging to see the plaque and analyze blood cells at a detailed level. The goal is to understand how plaque features relate to immune responses and f…
Sponsor: Harbin Medical University • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:16 UTC